COMMUNIQUÉS West-GlobeNewswire

AxoGen, Inc. Pre-Announces Financial and Operational Results
07/01/2019
Q4 Revenue of at least $23.4 million, a 38% YoY increase FY 2018 Revenue of at least $83.9 million, a 39% YoY increase Company reaffirms 2019 financial guidance and provides business update Appoints Chris Crisman to [...]
La Jolla Pharmaceutical Company Highlights Recent Corporate Progress and Key Objectives
07/01/2019
- Fourth-Quarter 2018 Net Sales of GIAPREZA Were Approximately $4.2 Million, Up 20% from the Third Quarter of 2018 - - Full-Year 2019 Net Sales Guidance for GIAPREZA of $24 Million to $28 Million - - Decision on [...]
Alphatec Announces 2018 Preliminary Revenue Results, 2019 Revenue Outlook, and Senior Leadership Changes
07/01/2019
CARLSBAD, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or “the Company”) (Nasdaq: ATEC) today announced preliminary revenue results for the fourth quarter and full year ended December 31, [...]
Ascendis Pharma A/S Introduces Vision 3x3: A Strategic Roadmap Through 2025 to Achieve Sustainable Growth Using Multiple Approaches
07/01/2019
COPENHAGEN, Denmark, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon ™ technologies to address significant unmet medical needs, [...]
Editas Medicine Reports on Recent Progress at J.P. Morgan Healthcare Conference
07/01/2019
CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- In a presentation to investors on Wednesday, January 9, 2019, at 9:00 a.m. PST at the 37th Annual J.P. Morgan Healthcare Conference, Editas Medicine, Inc. (Nasdaq: [...]
Ceapro Announces 2019 Management Team and Grant of Stock Options and Restricted Share Units
07/01/2019
EDMONTON, Alberta, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]
HealthEquity Announces Fiscal Year 2019 Sales Presentation at JP Morgan Healthcare Conference
07/01/2019
DRAPER, Utah, Jan. 07, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent health savings account (“HSA") custodian, today announced significant [...]
State of Georgia expands partnership with Sharecare to improve health of state employees, teachers and their families
07/01/2019
Walmart to contribute annual incentive dollars earned through Sharecare to help eligible State Health Benefit Plan members purchase prescription medications and vision products at its retail stores; Emory Healthcare and [...]
AxoGen Appoints Christopher Crisman as Vice President, U.S. Sales
07/01/2019
Brings nearly 30 years of medical device sales execution expertise having successfully built and led several large, productive sales organizations ALACHUA, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: [...]
CV Sciences, Inc. to Present at the 21st Annual ICR Conference
07/01/2019
LAS VEGAS, Jan. 07, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer of its industry-dominating brand of hemp CBD products, PlusCBD Oil™ , today announced that Joseph Dowling [...]
Rezolute Announces $25 Million Private Placement -- Potential Total Investment of $45 Million
07/01/2019
REDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “Company”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for [...]
Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners
07/01/2019
Novos to provide fully integrated commercial function for Evoke and non-dilutive financing for the commercialization of Gimoti, extending cash runway into 2020 Evoke will retain greater than 80% of product profits [...]
Bellerophon Announces Top-line Results from Cohort 1 of the INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
07/01/2019
Statistically Significant Improvements in Multiple Clinically Meaningful Activity Parameters Demonstrated WARREN, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or [...]
Homology Medicines Advances First Gene Editing Development Candidate into IND-Enabling Studies for Pediatric Patients with Phenylketonuria
07/01/2019
- Data Demonstrates Highly Efficient and Selective In Vivo Gene Editing in a Humanized Murine Model - - New Internal GMP Manufacturing Capability to Support Gene Therapy and Gene Editing Programs - BEDFORD, Mass., Jan. [...]
Assure Holdings Appoints Paul Webster as Vice President of Strategy
07/01/2019
DENVER, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative neuromonitoring services, has appointed Paul Webster as its vice [...]
PSIQ Begins 2019 Expansion by Presenting Its Product Catalog at the Hemp/CBD Health & Beauty Care EPPS Trade Show With Scheduled Meetings With Some of the Largest Mass Market Retailers in the USA
07/01/2019
SUNRISE, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces its subsidiary Elite Products International, Inc. will be attending the Efficient Collaborative Retail Marketing (“ECRM [...]
Cocrystal Announces Board Changes
07/01/2019
BOTHELL, WA, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc., a biotechnology company with a proprietary technology platform focused on developing medicines to treat viral diseases, today announced changes to [...]
Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY
07/01/2019
AUSTIN, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a clinical-stage drug development company, today announced two new publications for its drug candidate, REMOXY ER (extended-release [...]
Cutera Announces Leadership Change and Preliminary Financial Results for Full Year 2018
07/01/2019
CEO James Reinstein Resigns as President, Chief Executive Officer and Board member COO Jason Richey to Serve as Interim CEO BRISBANE, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Cutera, Inc. ( CUTR ) (“Cutera” or the “ [...]

Pages